|
KMID : 0882420200950020089
|
|
Korean Journal of Medicine
2020 Volume.95 No. 2 p.89 ~ p.94
|
|
|
Osteoporosis in Patients with Chronic Kidney Disease
|
|
Kwon Young-Joo
|
|
|
Abstract
|
|
|
|
Osteoporosis in chronic kidney disease (CKD) is also referred to as ‘CKD with low bone mineral density (BMD)’, because the cause of low BMD in CKD includes chronic kidney disease-mineral bone disorders (CKD-MBD) such as secondary hyperparathyroidism, osteomalacia, and adynamic bone disease. Diagnostic methods of osteoporosis in CKD include FRAX®, BMD, and bone turnover markers as well as CKD-MBD biochemical parameters- calcium, P, alkaline phosphatase, PTH, and 25(OH)D3. The management of osteoporosis in CKD prioritizes CKD-MBD management over selection of bone anti-resorptive agents or osteo-anabolic agents according to clinical and laboratory findings.
|
|
|
KEYWORD
|
|
|
Chronic kidney failure, Chronic kidney insufficiency, Osteoporosis, Chronic kidney disease mineral bone disorder
|
|
|
FullTexts / Linksout information
|
|
 
|
|
|
Listed journal information
|
|
  
|
|